Gene variation boosts heart disease risk from chemo

05/21/2010 | HealthDay News

Children with CBR gene variations who are given anthracycline chemotherapy for cancer have a higher risk of developing heart disease later in life, a study found. Researchers said the data could one day help doctors screen children for the variation and offer alternative therapies that don't damage the heart.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI